Literature DB >> 24629634

Programmed death-1 receptor suppresses γ-IFN producing NKT cells in human tuberculosis.

Amar Singh1, Aparajit Ballav Dey2, Anant Mohan2, Dipendra Kumar Mitra3.   

Abstract

IFN-γ biased Th1 effector immune response is crucial for containment of Mycobacterium tuberculosis infection. Various T cell subsets with regulatory function dictate the generation of Th1 like cells. NKT cells are a specialized T cell subset known to be activated early in immune response and control T cell response via release of immunoregulatory cytokines like IFN-γ, IL-4 and IL-10. M. tuberculosis, with abundance of its cell wall lipids may potently activate NKT cells resulting in cytokine production and PD-1 expression. In this study, among 49 treatment naive active pulmonary tuberculosis patients, we found a higher percentage of PD1(+) NKT cells correlating with sputum bacillary load. Furthermore, blocking PD-1 increased the number of IFN-γ producing NKT cells by inhibiting their apoptosis. Moreover, peripheral frequency of NKT cells declined with therapy suggesting their role in host T cell response. In this study, we concluded that PD-1 preferentially induces apoptosis of IFN-γ producing NKT cells while sparing NKT cells that produce IL-4. Such a polarized NKT cell function may impose a Th2 bias on the ensuing effector T cell response leading to inefficient clearance of M. tuberculosis. Inhibiting PD-1 may therefore alter the T cell response in favor of the host by rescuing type 1 NKT cells from apoptosis and boosting Th1 effector T cell functions against M. tuberculosis.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Effector T cells; Inteferon-gamma; Natural killer T cell; Programmed death-1; T helper-1

Mesh:

Substances:

Year:  2014        PMID: 24629634     DOI: 10.1016/j.tube.2014.01.005

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  15 in total

1.  The characteristics of NK cells in Schistosoma japonicum-infected mouse spleens.

Authors:  Lu Li; Hefei Cha; Xiuxue Yu; Hongyan Xie; Changyou Wu; Nuo Dong; Jun Huang
Journal:  Parasitol Res       Date:  2015-08-29       Impact factor: 2.289

2.  Mycoplasma bovis-Induced Inhibition of Bovine Peripheral Blood Mononuclear Cell Proliferation Is Ameliorated after Blocking the Immune-Inhibitory Programmed Death 1 Receptor.

Authors:  Farhan S Cyprian; Steve Jimbo; Muhammad Suleman; Teresia Maina; Tracy Prysliak; Claire Windeyer; Jose Perez-Casal
Journal:  Infect Immun       Date:  2018-02-20       Impact factor: 3.441

3.  T-cell Homing Therapy for Reducing Regulatory T Cells and Preserving Effector T-cell Function in Large Solid Tumors.

Authors:  Jiemiao Hu; Chuang Sun; Chantale Bernatchez; Xueqing Xia; Patrick Hwu; Gianpietro Dotti; Shulin Li
Journal:  Clin Cancer Res       Date:  2018-02-01       Impact factor: 12.531

4.  Programmed death-1+ T cells inhibit effector T cells at the pathological site of miliary tuberculosis.

Authors:  A Singh; A Mohan; A B Dey; D K Mitra
Journal:  Clin Exp Immunol       Date:  2016-11-24       Impact factor: 4.330

5.  PD-1, PD-L1 and PD-L2 Gene Expression on T-Cells and Natural Killer Cells Declines in Conjunction with a Reduction in PD-1 Protein during the Intensive Phase of Tuberculosis Treatment.

Authors:  Syeda S Hassan; Muhammad Akram; Elizabeth C King; Hazel M Dockrell; Jacqueline M Cliff
Journal:  PLoS One       Date:  2015-09-11       Impact factor: 3.240

Review 6.  Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis.

Authors:  Alimuddin Zumla; Martin Rao; Ernest Dodoo; Markus Maeurer
Journal:  BMC Med       Date:  2016-06-15       Impact factor: 8.775

7.  Blockade of programmed death-1/programmed death ligand pathway enhances the antitumor immunity of human invariant natural killer T cells.

Authors:  Toshiko Kamata; Akane Suzuki; Naoko Mise; Fumie Ihara; Mariko Takami; Yuji Makita; Atsushi Horinaka; Kazuaki Harada; Naoki Kunii; Shigetoshi Yoshida; Ichiro Yoshino; Toshinori Nakayama; Shinichiro Motohashi
Journal:  Cancer Immunol Immunother       Date:  2016-09-15       Impact factor: 6.968

Review 8.  Bolstering Immunity through Pattern Recognition Receptors: A Unique Approach to Control Tuberculosis.

Authors:  Susanta Pahari; Gurpreet Kaur; Mohammad Aqdas; Shikha Negi; Deepyan Chatterjee; Hilal Bashir; Sanpreet Singh; Javed N Agrewala
Journal:  Front Immunol       Date:  2017-08-02       Impact factor: 7.561

Review 9.  T-Cell Therapy: Options for Infectious Diseases.

Authors:  Shreemanta K Parida; Thomas Poiret; Liu Zhenjiang; Qingda Meng; Jan Heyckendorf; Christoph Lange; Aditya S Ambati; Martin V Rao; Davide Valentini; Giovanni Ferrara; Elena Rangelova; Ernest Dodoo; Alimuddin Zumla; Markus Maeurer
Journal:  Clin Infect Dis       Date:  2015-10-15       Impact factor: 9.079

Review 10.  The Etiologic Role of Infectious Antigens in Sarcoidosis Pathogenesis.

Authors:  Lindsay J Celada; Charlene Hawkins; Wonder P Drake
Journal:  Clin Chest Med       Date:  2015-09-19       Impact factor: 2.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.